# Accendra Health Inc (ACH)

> Cited company facts from SEC filings, by Steadybase. Web page: https://steadybase.io/company/accendra-health-inc/ JSON: https://steadybase.io/company/accendra-health-inc.json Checked Nov 11, 2026. Latest filing read: Nov 6, 2026.

## Company

- Legal name: ACCENDRA HEALTH INC/VA/
- Ticker: ACH (NYSE)
- SEC CIK: 0000075252
- Industry: Wholesale-Medical, Dental & Hospital Equipment & Supplies (SIC 5047)
- Headquarters: Glen Allen, VA
- Fiscal year ends: December 31
- SEC filer category: Large accelerated filer
- Website: accendrahealth.com
- LinkedIn: https://www.linkedin.com/company/virginia-premier-health-plan-inc-
- Next earnings date: Nov 9, 2026 (estimated from past 8-K timing)

## Key facts

- Revenue: $2.8B for the fiscal year ended Dec 31, 2025 (10-K filed Feb 20, 2026). Source: https://www.sec.gov/Archives/edgar/data/75252/000110465926018169/0001104659-26-018169-index.html
- Operating income: $27.5M for the fiscal year ended Dec 31, 2025 (10-K filed Feb 20, 2026). Source: https://www.sec.gov/Archives/edgar/data/75252/000110465926018169/0001104659-26-018169-index.html
- Net income: -$1.1B for the fiscal year ended Dec 31, 2025 (10-K filed Feb 20, 2026). Source: https://www.sec.gov/Archives/edgar/data/75252/000110465926018169/0001104659-26-018169-index.html
- SG&A: $1.1B for the fiscal year ended Dec 31, 2025 (10-K filed Feb 20, 2026). Source: https://www.sec.gov/Archives/edgar/data/75252/000110465926018169/0001104659-26-018169-index.html
- Employees: 6,500 as of , as reported in an SEC filing. Source: https://www.sec.gov/Archives/edgar/data/75252/000110465926018169/omi-20251231x10k.htm
- Shares outstanding: 76,924,334 as of Sep 30, 2026 (10-Q filed Nov 6, 2026). Source: https://www.sec.gov/Archives/edgar/data/75252/000110465926123491/0001104659-26-123491-index.html
- Auditor: Kpmg, LLP, Richmond, VA, named in the latest 10-K. Source: https://www.sec.gov/Archives/edgar/data/75252/000110465926018169/omi-20251231x10k.htm

## Business

Accendra Health, Inc. (f/k/a Owens & Minor, Inc.) and subsidiaries (Accendra Health, we, us, our or the Company) is a leading nationwide provider of products, technology, and services that supports health beyond the hospital for millions of people each year. We connect patients, providers, and insurers, delivering innovative solutions that help promote better health outcomes and improve quality of life for people living with chronic, complex, and acute health conditions.

Source: Item 1. Business, https://www.sec.gov/Archives/edgar/data/75252/000110465926018169/omi-20251231x10k.htm

## Annual results

| Fiscal year ended | Revenue | Operating income | Net income | SG&A |
|---|---|---|---|---|
| Dec 31, 2025 | $2.8B | $27.5M | -$1.1B | $1.1B |
| Dec 31, 2024 | $2.7B | -$217.7M | -$362.7M | $1.1B |
| Dec 31, 2023 | $2.6B | $133.2M | -$41.3M | $1.0B |
| Dec 31, 2022 | $10.0B | $142.9M | $22.4M | $1.6B |
| Dec 31, 2021 | $9.8B | $368.5M | $221.6M | $1.1B |

Each figure comes from the annual report for that year. Filing links for every figure: https://steadybase.io/company/accendra-health-inc.json

## Officers and directors

- Kenneth Gardner-Smith, President & CEO. Source: Form 4 filed Oct 6, 2026, https://www.sec.gov/Archives/edgar/data/75252/000007525226000043/0000075252-26-000043-index.htm
- Jonathan A. Leon, EVP & CFO. LinkedIn: https://linkedin.com/in/jon-leon. Source: Form 4 filed Sep 24, 2026, https://www.sec.gov/Archives/edgar/data/75252/000007525226000041/0000075252-26-000041-index.htm
- Perry A. Bernocchi, EVP, Chief Operating Officer. Source: Form 4 filed May 19, 2026, https://www.sec.gov/Archives/edgar/data/75252/000007525226000033/0000075252-26-000033-index.htm
- Perry Bernocchi, Executive Vice President & Chief Operating Officer. Source: 10-K filed Feb 20, 2026, https://www.sec.gov/Archives/edgar/data/75252/000110465926018169/omi-20251231x10k.htm
- Scott MacRae Lloyd, EVP, Chief Commercial Officer. Source: Form 3 filed Nov 4, 2026, https://www.sec.gov/Archives/edgar/data/75252/000007525226000045/0000075252-26-000045-index.htm
- Heath H. Galloway, EVP,General Counsel & CorpSecy. Source: Form 4 filed May 20, 2026, https://www.sec.gov/Archives/edgar/data/75252/000007525226000038/0000075252-26-000038-index.htm
- Andrew G. Long, EVP, CEO P&HS. Source: Form 4 filed Nov 20, 2025, https://www.sec.gov/Archives/edgar/data/75252/000007525225000006/0000075252-25-000006-index.htm
- Gwendolyn M. Bingham, Board member (per proxy). Source: DEF 14A filed Apr 2, 2026, https://www.sec.gov/Archives/edgar/data/75252/000110465926038823/ach-20260514xdef14a.htm
- Mark A. Beck, Board member (per proxy). Source: DEF 14A filed Apr 2, 2026, https://www.sec.gov/Archives/edgar/data/75252/000110465926038823/ach-20260514xdef14a.htm

## Recent 8-K events

- Nov 5, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/75252/000110465926123312/ach-20261105x8k.htm
- Nov 3, 2026: Item 5.02, Departure or appointment of directors or officers; compensation; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/75252/000110465926122072/ach-20261029x8k.htm
- Nov 2, 2026: Item 1.01, Entry into a material definitive agreement; Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/75252/000110465926120905/ach-20261029x8k.htm
- Oct 30, 2026: Item 3.01, Notice of delisting or failure to meet listing standards; Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/75252/000110465926120716/ach-20261027x8k.htm
- Oct 9, 2026: Item 3.01, Notice of delisting or failure to meet listing standards; Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/75252/000110465926115043/ach-20261006x8k.htm
- Sep 17, 2026: Item 5.02, Departure or appointment of directors or officers; compensation; Item 7.01, Regulation FD disclosure; Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/75252/000110465926108405/ach-20260916x8k.htm
- Aug 17, 2026: Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/75252/000110465926097517/tm2622667d5_8k.htm
- Aug 10, 2026: Item 1.01, Entry into a material definitive agreement; Item 3.03, Material modification to rights of security holders; Item 5.03, Amendments to articles or bylaws; change in fiscal year; Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/75252/000110465926093381/tm2622667d3_8k.htm
- Aug 10, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/75252/000110465926092999/tm2622667d2_8k.htm
- Aug 10, 2026: Item 5.02, Departure or appointment of directors or officers; compensation; Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/75252/000110465926092973/tm2622667d1_8k.htm

## What management said

- "Over the several weeks since I started, a number of themes have become clear to me. We have strong brands, favorable end markets, and a teammate population dedicated to our mission, Bringing Care To Life. It is equally clear to me that our results to date in 2026 have fallen well short of our expectations and potential. We have identified four key areas which are critical to our continued transformation and returning the business to the kind of profitability that our sharehol" Kenny Gardner-Smith, President & Chief Executive Officer, Accendra Health (8-K filed Nov 5, 2026). Source: https://www.sec.gov/Archives/edgar/data/75252/000110465926123312/ach-ex99d1.htm

## Latest filings

- 8-K filed Nov 3, 2026: https://www.sec.gov/Archives/edgar/data/75252/000110465926122072/ach-20261029x8k.htm
- 10-K filed Feb 20, 2026: https://www.sec.gov/Archives/edgar/data/75252/000110465926018169/omi-20251231x10k.htm
- 10-Q filed Aug 10, 2026: https://www.sec.gov/Archives/edgar/data/75252/000110465926093177/ach-20260630x10q.htm
- DEF 14A filed Oct 29, 2026: https://www.sec.gov/Archives/edgar/data/75252/000110465926120208/tm2627523-2_def14a.htm

## About this data

SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from.
Steadybase covers US-headquartered public companies that file with the SEC. API and MCP access: https://steadybase.io/docs/